Cronkhite-Canada Syndrome: A Diagnostic Challenge and Management With Vedolizumab
American Journal of Case Reports · 21.04.2026 · 27
DOI: 10.12659/ajcr.950621 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Case Reports, online erschienen am 21.04.2026. Verfasst von Aida Nasirishargh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, UC Davis Health, University of California Davis, Sacramento, CA, USA. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Cronkhite-Canada Syndrome, Gastrointestinal Agents. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, UC Davis Health, University of California Davis, Sacramento, CA, USA.
- Division of Gastroenterology, UC Davis Health, University of California Davis, Sacramento, CA, USA.
- Department of Pathology and Laboratory Medicine, UC Davis Health, University of California Davis, Sacramento, CA, USA.
ORCID-Profile: Aida Nasirishargh, Eric J Mao
Zitieren
APA
Nasirishargh, A., Pecha, R. L., Aggarwal, A., Schaberg, K., Wei, D., & Mao, E. J. (2026). Cronkhite-Canada Syndrome: A Diagnostic Challenge and Management With Vedolizumab. American Journal of Case Reports, 27. https://doi.org/10.12659/ajcr.950621
Vancouver
Nasirishargh A, Pecha RL, Aggarwal A, Schaberg K, Wei D, Mao EJ. Cronkhite-Canada Syndrome: A Diagnostic Challenge and Management With Vedolizumab. American Journal of Case Reports. 2026;27. doi:10.12659/ajcr.950621
BibTeX
@article{Nasirishargh2026,
author = {Nasirishargh, Aida and Pecha, Robert Luke and Aggarwal, Ashna and Schaberg, Kurt and Wei, Dongguang and Mao, Eric J},
title = {Cronkhite-Canada Syndrome: A Diagnostic Challenge and Management With Vedolizumab},
journal = {American Journal of Case Reports},
year = {2026},
volume = {27},
doi = {10.12659/ajcr.950621}
}
EUVIMED